From her first interview for a job on Wall Street through her successful career as a trader and financial consultant, Terri Duhon (the author of How the Trading Floor Really Works) offers a fascinating look into the complex field of risk management.

Scott Patterson, Wall Street Journal staff reporter and author of The Quants, outlines the incredible and frightening paradigm of high frequency trading.

Bitcoin – an emerging peer-to-peer payment system, platform, and cryptocurrency – is taking the world by storm. Reggie Middleton joins us with Andreas Antonopolous, Dave Scotese, and Sam Guzik to crystallize our undertanding of Bitcoin, Crowdfunding, and “The Future of Money”.

We continue our exploration of precious metals and their value as real money throughout global systemic transition and the predicted failure of paper money. Join us with James Turk and learn what you can do to protect yourself when the money bubble pops!

Grameen Bank founder Dr. Muhammad Yunus is the brainchild behind micro-finance. Learn more about this exemplary human being in our special interview!

Richard Bach – Worth the Wait

by on September 15, 2014      

in Arts & Entertainment

After a year of planning, we bring you Richard Bach, bestselling author of Jonathan Livingston Seagull, in an uplifting conversation about creativity and life!

Plum Village director Sister Chan Khong discusses peace, community, love, and kindness.

Artist, Icelandic MP, and political activist Birgitta Jónsdóttir joins us for an in-depth discussion of internet privacy, freedom of speech, and the opportunities before Iceland today.

LEAP director, former MI5 agent, and whistleblower Annie Machon answers difficult questions that get to the heart of a global surveillance culture and a military industrial complex whose ramifications are difficult to imagine.

John Davis, the CEO of the Northwest Patient Resource Center (NWPRC), is at the heart of the burgeoning cannabis industry in the United States. As the reality of marijuana legalization takes root in the U.S., John discusses the issues and the fine points of stewarding a massive drug policy change in the United States.